NCT06979544Phase 3Completed

A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD

Study sponsor: Lipocine Inc. · LPCN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-01-16Actual
Enrollment · participants90Actual
Source updated2026-02-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 80 participants (planned). After: 90 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Apr 2026. After: 16 Jan 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview